{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:46:00Z","timestamp":1763480760195},"reference-count":23,"publisher":"Institute of Biochemistry","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BIOMED KHIM"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>A novel series of 5\u2032-benzylidene-3\u2032-phenylspiro[indoline-3,2\u2032-thiazolidine]-2,4\u2032(1H)-diones 6a-d and spiro[indoline-3,2\u2032-thiazolo[5,4-e]pyrimido[1,2-a]pyrimidin]-2(1H)-one 9a-d derivatives have been synthesized. All the newly synthesized compounds were evaluated for antifungal and anti-candidiasis activity by using Disc Diffusion and Modified Microdilution methods. The antimicrobial experiments have shown that the synthesized compounds demonstrated broad-spectrum antifungal activity in vitro. Among them, compounds 9a-9d had stronger antifungal activity against Trichophyton rubrum, Trichophyton mentagrophytes, and Candida albicans; compounds 6a-d also showed significant antifungal activity against selected fungal strains as compared to ketoconazole, the reference antifungal drug. The evaluation of antifungal activity against drug-resistant fungal variants showed that the designed compounds had significant antifungal activity against the tested variants. The combination of compounds (6a-d) and (9a-d) exhibited that the synthesized compounds had synergistic effects or additive effects. These results demonstrated that the synthesized compounds were putative chitin synthase inhibitors exhibiting broad spectrum antifungal activities. The present results indicate that novel spiro pyrimidine derivatives can be used as an active pharmaceutical ingredient for novel drug candidate for treatment of dermatophytosis and other fungal agents.<\/jats:p>","DOI":"10.18097\/pbmc20247003180","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T09:57:43Z","timestamp":1719568663000},"page":"180-186","source":"Crossref","is-referenced-by-count":1,"title":["Novel spiro[indoline-3,2\u2032thiazolo[5,4-e]pyrimido[1,2-a] pyrimidine] derivatives as possible anti-dermatophytic and anti-candidiasis agent"],"prefix":"10.18097","volume":"70","author":[{"given":"G.","family":"Sharma","sequence":"first","affiliation":[{"name":"Department of Chemistry, MPS International, Jaipur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Mahatma Gandhi University of Medical Science and Technology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7443","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Holla B.S., Mahalinga M., Karthikeyan M.S., Akberali P.M., Shetty N.S. (2006) Synthesis of some novel pyrazolo[3,4-d] pyrimidine derivatives as potential antimicrobial agents. Bioorg. Med. Chem., 14(6), 2040\u20132047.","DOI":"10.1016\/j.bmc.2005.10.053"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Kaplancikli Z.A., Turan-Zitouni G., Ozdemir A., Revial G. (2008) New triazole and triazolothiadiazine derivatives as possible antimicrobial agents. Eur. J. Med. Chem., 43(1), 155\u2013159.","DOI":"10.1016\/j.ejmech.2007.03.019"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Pathakumari B., Liang G., Liu W. (2020) Immune defence to invasive fungal infections: A comprehensive review. Biomed. Pharmacother., 130, 1105.","DOI":"10.1016\/j.biopha.2020.110550"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Pristov K.E., Ghannoum M.A. (2019) Resistance of Candida to azoles and echinocandins worldwide. Clin. Microbiol. Infect., 25(7), 792\u2013798.","DOI":"10.1016\/j.cmi.2019.03.028"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Cort\u00e9s J.C.G., Curto M.\u00c1., Carvalho V.S.D., P\u00e9rez P., Ribas J.C. (2019) The fungal cell wall as a target for the development of new antifungal therapies. Biotechnol. Adv., 37(6), 10735.","DOI":"10.1016\/j.biotechadv.2019.02.008"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Lenardon M.D., Munro C.A., Gow N.E.R. (2010) Chitin synthesis and fungal pathogenesis. Curr. Opin. Microbiol., 13(4), 416\u2013423.","DOI":"10.1016\/j.mib.2010.05.002"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Curto M.\u00c1., Butassi E., Ribas J.C., Svetaz L.A., Cort\u00e9s J.C.G. (2021) Natural products targeting the synthesis of \u03b2(1,3)-D-glucan and chitin of the fungal cell wall. Existing drugs and recent findings. Phytomedicine, 88, 153556.","DOI":"10.1016\/j.phymed.2021.153556"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Noureldin N.A., Kothayer H., Lashine E.M., Baraka M.M., Huang Y., Li B., Ji Q. (2018) Design, synthesis and biological evaluation of novel quinazoline-2,4-diones conjugated with different amino acids as potential chitin synthase inhibitors. Eur. J. Med. Chem., 152, 560\u2013569.","DOI":"10.1016\/j.ejmech.2018.05.001"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Masubuchi K., Tangiguchi M., Umeda M., Hattori I., Suda K., Kohchi H., Isshik Y., Sakai T., Kochchi M., Shirai M. (2022) Synthesis and structure-activity relationships of novel fungal chitin synthase inhibitors. Bioorg. Med. Chem. Lett., 10(13), 1459\u20131462.","DOI":"10.1016\/s0960-894x(00)00257-2"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Bongomin F., Gago S., Oladel R.O. (2017) Global and multi-national prevalence of fungal diseases \u2014 estimate precision. J. Fungi (Basel), 3(4), 57.","DOI":"10.3390\/jof3040057"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Limper A.H., Adenis A., Le T., Harrison T.S. (2017) Fungal infections in HIV\/AIDS. Lancet Infect. Dis., 17(11), 334\u2013343.","DOI":"10.1016\/S1473-3099(17)30303-1"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Robbins N., Wright G.D., Cowen L.D. (2016) Antifungal drugs: The current armamentarium and development of new agents. Microbiol. Spectr., 4(5), DOI: 10.1128\/microbiolspec.FUNK-0002-2016.","DOI":"10.1128\/microbiolspec.FUNK-0002-2016"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Mroczy\u0144ska M, Brillowska-D\u0105browska A. (2022) Review on current status of echinocandins use. Antibiotics (Basel), 9(5), 227.","DOI":"10.3390\/antibiotics9050227"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Dandia A., Sharma G., Singh R., Laxkar A. (2009) Anew strategy for the synthesis of novel spiro [indoline-3,2\u2032- thiazolo [5, 4-e] pyrimido [1, 2-a] pyrimidine] derivatives. Arkivoc, 14, 100\u2013108.","DOI":"10.3998\/ark.5550190.0010.e09"},{"key":"ref15","unstructured":"Gould J.C., Bowie J.H. (1952) The determination of bacterial sensitivity to antibiotics. Edinburgh Med. J., 59(4), 178\u2013199."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Provine H., Hadley S. (2000) Preliminary evaluation of a semisolid agar antifungal susceptibility test for yeasts and molds. J Clin. Microbiol., 38(2), 537\u2013541.","DOI":"10.1128\/jcm.38.2.537-541.2000"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Wu H., Du C., Xu Y., Liu L., Zhou X., Ji Q. (2022) Design, synthesis, and biological evaluation of novel spiro[pyrrolidine-2,3\u2032-quinolin]-2\u2032-one derivatives as potential chitin synthase inhibitors and antifungal agents. Eur. J. Med. Chem., 233, 114208.","DOI":"10.1016\/j.ejmech.2022.114208"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Rani N.V., Kunta R. (2021) PEG-400 promoted a simple, efficient and eco-friendly synthesis of functionalized novel isoxazolyl pyrido[2,3-d]pyrimidines and their antimicrobial and anti-inflammatory activity. Synthetic Communications, 51(8), 1171\u20131183.","DOI":"10.1080\/00397911.2021.1871759"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Rajesh S.M., Kumar R.S., Libertsen L.A., Perumal S., Yogeeswari P., Sriram D. (2011) An atomefficient, solvent-free, green synthesis and antimycobacterial evaluation of 2-amino-6-methyl-4-aryl-8-[(e)-arylmethylidene]-5,6,7,8- tetrahydro-4h-pyrano[3,2-c]pyridine-3-carbonitriles. Bioorg. Med. Chem. Lett., 21(10), 3012\u20133016.","DOI":"10.1016\/j.bmcl.2011.03.045"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Abdelhameed R.M., Darwesh O.M. El-Shahat M. (2020) Synthesis of arylidene hydrazinylpyrido[2,3-d]pyrimidin- 4-ones as potent anti-microbial agents. Heliyon, 6(9), e04956.","DOI":"10.1016\/j.heliyon.2020.e04956"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Elsaedany S.K., AbdEllatif zein M., AbdElRehim E.M., Keshk R.M. (2021) Synthesis and biological activity studies of novel pyrido[2,3-d]pyrimidines and pyrido[2,3-d]triazines. Russ. J. Bioorg. Chem., 47(2), 552\u2013560.","DOI":"10.1134\/S1068162021020114"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"de Goey D.A., Betebenner D.A., Grampovnik D.J., Liu D., Pratt J.K., Tufano M.D., He W., Krishnan P., Pilot-Matias T.J., Marsh K.C., Molla A., Kempf D.J., Maring C.J. (2013) Discovery of pyrido[2,3-d]pyrimidine-based inhibitors of HCV NS5A. Bioorg. Med. Chem. Lett., 23(12), 3627\u20133630.","DOI":"10.1016\/j.bmcl.2013.04.009"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Wang M., Yang J., Yuan M., Xue L., Li H., Tian C., Wang X., Liu J., Zhang Z. (2017) Synthesis and antiproliferative activity of a series of novel 6-substituted pyrido[3,2-d]pyrimidines as potential nonclassical lipophilic antifolates targeting dihydrofolate reductase. Eur. J. Med. Chem., 128, 88\u201397.","DOI":"10.1016\/j.ejmech.2017.01.033"}],"container-title":["Biomeditsinskaya Khimiya"],"original-title":[],"language":"ru","deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T09:58:20Z","timestamp":1719568700000},"score":1,"resource":{"primary":{"URL":"http:\/\/pbmc.ibmc.msk.ru\/en\/article-en\/PBMC-2024-70-3-180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.18097\/pbmc20247003180","relation":{},"ISSN":["2310-6905","2310-6972"],"issn-type":[{"value":"2310-6905","type":"electronic"},{"value":"2310-6972","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}